- Expires: September 24, 2025
- Credit: 1.00hr(s)
- AAPA, CME, ILNA, IPCE, MOC
- Specialties: Epstein-Barr virus (EBV), Post-Transplant Lymphoproliferative Disorders (PTLD)
This 4 part-15 minute segmented vodcast/podcast will unite dermatology and allergy clinicians, who provide care for patients with moderate-to-severe atopic dermatitis (M-S AD). Patients with M-S AD often experience disease-related flare events, which can have a substantial impact on quality of life. However, advancements in systemic biologic agents have shown promise regarding their efficacy to the treatment and long-term management of flare events with minimal impact on patient safety. Expert faculty, Peter Lio, MD, FAAD; and Mark Boguniewicz, MD; TJ Chao, MPAS, PA-C; and Victoria Lazareth, MA, MSN, NP-C, DCNP will discuss how to choose treatment and manage patients with M-S AD to prevent flare events, the impact that the disease and flare events have on quality of life including how to best assess patient symptoms, and strategies that ensure shared decision-making and collaboration with interdisciplinary teams to ensure optimal clinical outcomes for patients.